Bausch Health Companies Shareholder Engagement Presentation Deck
19
Reconciliation: Adjusted EBITDA¹
In USD millions
Net loss attributable to Bausch Health Companies Inc.
Interest expense, net
Benefit from income taxes
Depreciation and amortization
EBITDA
Adjustments:
Asset impairments, including loss on assets held for sale
Goodwill impairments
Restructuring and integration costs
Acquisition-related costs and adjustments (excluding
amortization of intangible assets)
Loss on extinguishment of debt
Share-based compensation
Separation costs, separation-related costs, IPO costs
IPO-related costs
Other adjustments:
Litigation and other matters
IT infrastructure investment
Legal and other professional fees
Net gain on sale of assets
Acquired in-process research and development costs
Other
2
Adjusted EBITDA (non-GAAP) ²
$
Dec-21
$
(948) $
1,419
(87)
1,552
1,936
234
469
18
11
62
128
164
356
27
54
(2)
8
7
3,472
$
Dec-20
(560)
1,521
(375)
1,825
2,411
114
11
48
59
105
32
422
21
39
(1)
32
1
3,294
1. This is a non-GAAP measure or non-GAAP ratio. See Appendix for further information on non-GAAP measures and ratios, including reconciliations of historic non-GAAP measures to
their most directly comparable GAAP measure.
BAUSCH- HealthView entire presentation